drugset / Trial / NCT06212596
Selinexor, Cyclophosphamide and Prednisone in Myeloma
RandomizedParallel-groupOpen-labelTreatment
Summary
The trial is designed as a randomised, controlled, open, parallel group, multi-centre phase II trial to evaluate clinical efficacy of selinexor in combination with cyclophosphamide and prednisone.
Timeline
- Start
- 2018-07-16
- Primary completion
- 2022-10-25
- Completion
- 2023-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selinexor | Other / unclassified | — | Oral |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Prednisone | Other / unclassified | — | — |